Hoth Therapeutics (HOTH)
(Real Time Quote from BATS)
$0.66 USD
-0.03 (-4.35%)
Updated Aug 2, 2024 01:08 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.39 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.57 | 0.12 | 54.84 |
Next Quarter Estimate | -0.36 | 7.81 | 63.00 |
Next Year Estimate | -0.86 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 39.13 | 15.80 | 15.67 |
Next Year | 38.57 | 10.10 | 11.34 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.43 | 2.20 |
Price/Cash Flow (MRFY) | NA | 16.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -12.31% |
Return on Equity (TTM) | -83.04% | -15.05% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.